Premium
Assessment of subclinical diabetic cardiomyopathy by speckle‐tracking imaging
Author(s) -
Minciună IoanAlexandru,
Hilda Orășan Olga,
Minciună Iulia,
Lazar AndradaLuciana,
SitarTăut Adela Viviana,
Oltean Monica,
Tomoaia Raluca,
Puiu Mihai,
SitarTăut DanAndrei,
Pop Dana,
Cozma Angela
Publication year - 2021
Publication title -
european journal of clinical investigation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.164
H-Index - 107
eISSN - 1365-2362
pISSN - 0014-2972
DOI - 10.1111/eci.13475
Subject(s) - subclinical infection , medicine , cardiology , diastole , cardiomyopathy , heart failure , speckle tracking echocardiography , diabetic cardiomyopathy , cardiac dysfunction , blood pressure , ejection fraction
Background Diastolic dysfunction is traditionally believed to be the first subclinical manifestation of diabetic cardiomyopathy (DCM), leading to systolic dysfunction and then overt heart failure. However, in the last few years, several studies suggested that systolic subclinical dysfunction measured by speckle‐tracking echocardiography (STE) may appear ahead of diastolic dysfunction. In this review, the main endpoint is to show whether subclinical myocardial systolic dysfunction appears ahead of diastolic dysfunction and the implication this may have on the evolution and management of DCM. Materials and methods We performed a search in PubMed for all relevant publications on the assessment of DCM by STE from 1 June 2015 to 1 June 2020. Results and Conclusions The results illustrate that subclinical systolic dysfunction assessed by STE is present in early DCM stages, with or without the association of diastolic dysfunction. This could be a promising perspective for the early management of patients with DCM leading to the prevention of the overt form of disease.